For research use only
| Cat No. | ABC-SC003X |
| Product Type | Human iPSCs |
| Cell Type | Induced Pluripotent Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Cord Blood |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Leverage HighQC™ Human iPSC Line (Episomal, CB) derived from cord blood to support safe, integration-free reprogramming in cellular modeling.
HighQC™ Human iPSC Line (Episomal, CB) is a high-quality, integration-free induced pluripotent stem cell (iPSC) line derived from human cord blood (CB) mononuclear cells using non-viral episomal reprogramming methods. The cells exhibit typical human pluripotent stem cell morphology characterized by compact colonies with a high nuclear-to-cytoplasmic ratio and prominent nucleoli. They express key pluripotency markers including OCT4, SOX2, NANOG, TRA-1-60, and SSEA-4, and exhibit a normal and stable human karyotype. Validated to differentiate into ectoderm, mesoderm, and endoderm lineages, this cell line is well-suited for developmental biology and disease modeling applications.
| Product Code | HighQC™ Human iPSC Line (Episomal, CB), Episomal Cord Blood iPSC, Integration Free CB iPSC, Human iPSC Cord Blood Derived, HighQC iPSC CB Line |
| Species | Human |
| Cat.No | ABC-SC003X |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Induced Pluripotent Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Cord Blood |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human iPSCs |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
HighQC™ Human iPSC Line (Episomal,CB) is extensively used for disease modeling, drug screening, and regenerative medicine research. Its differentiation potential enables studies in neurodevelopment, cardiomyocyte biology, and hematopoiesis. In the study of disease mechanisms, this line could be used to simulate the pathological process of genetic or acquired diseases by directing differentiation into specific cell types (such as neurons, cardiomyocytes or hepatocytes). The episomal, integration-free nature makes it suitable for clinical translation and gene editing applications.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).